{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:16:49Z","timestamp":1756995409329},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":6170,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1990,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Prolactin (PRL) response to a single dose of intravenous haloperidol (0.5 mg) was measured as a marker of tuberoinfundibular dopamine (TIDA) activity in 24 neuroleptic\u2010free, male, psychotic patients. The PRL responses were then correlated with psychotic symptoms measured with Andreasen's Scales for the Assessment of Positive and Negative Symptoms (SAPS, SANS). Correlation analyses revealed a significant inverse relationship between PRL response and the severity of delusional symptoms. There was no significant correlation between the symptoms of hallucinations, formal thought disorder, or global negative symptoms and PRL response to haloperidol, nor were there any significant correlations between basal PRL and symptom severity. These results suggest that among the positive and negative symptoms associated with psychoses, only delusions may be associated with TIDA overactivity.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1990.tb01383.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T12:09:31Z","timestamp":1187870971000},"page":"271-274","source":"Crossref","is-referenced-by-count":13,"title":["Relationship of psychotic symptoms to haloperidol\u2010stimulated prolactin release"],"prefix":"10.1111","volume":"82","author":[{"given":"J.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A.","family":"Keks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. H.","family":"Minas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. S.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. L.","family":"Copolov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290070025006"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(80)90015-3"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426804"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(81)90047-0"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.144.10.1335"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/2.1.19"},{"key":"e_1_2_1_8_2","first-page":"229","article-title":"Brain dopamine receptors","volume":"32","author":"Seeman P.","year":"1980","journal-title":"Pharmacol Rev"},{"key":"e_1_2_1_9_2","volume-title":"The scale for the assessment of positive symptoms (SAPS)","author":"Andreasen NC.","year":"1983"},{"key":"e_1_2_1_10_2","volume-title":"The scale for the assessment of negative symptoms (SANS)","author":"Andreasen NC.","year":"1984"},{"key":"e_1_2_1_11_2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1980"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"e_1_2_1_13_2","volume-title":"Reproductive physiology method manual","author":"World Health Organization","year":"1985"},{"key":"e_1_2_1_14_2","volume-title":"BMDP statistical software","author":"Dixon WJ","year":"1983"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/11.3.471"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6207.66"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790220030005"},{"key":"e_1_2_1_18_2","first-page":"875","article-title":"Growth hormone responses to graded doses of apomorphine HCL in schizophrenia","volume":"18","author":"Cleghorn J.","year":"1983","journal-title":"Biol Psychiatry"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800120048010"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(86)90111-3"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760160102021"},{"key":"e_1_2_1_22_2","first-page":"95","article-title":"The phenomenology of experimentally\u2010induced amphetamine psychosis: preliminary observations","volume":"126","author":"Asgrist B","year":"1970","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_23_2","first-page":"209","volume-title":"Perspectives in schizophrenia research","author":"Henn FA.","year":"1980"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4880.122"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1957.tb40764.x"},{"key":"e_1_2_1_26_2","first-page":"90","article-title":"The use of LSD and ditran in the treatment of therapy resistant schizophrenics (symptom provocation approach)","volume":"30","author":"Hil TM","year":"1969","journal-title":"Dis Nerv Syst"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.37.8.941"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1974.tb09362.x"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.137.4.379"},{"key":"e_1_2_1_30_2","first-page":"43","volume-title":"Brain peptides and hormones","author":"Crow TJ","year":"1982"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1990.tb01383.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1990.tb01383.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T18:44:52Z","timestamp":1698000292000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1990.tb01383.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,10]]}},"alternative-id":["10.1111\/j.1600-0447.1990.tb01383.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1990.tb01383.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,10]]}}}